As shown in Figure 2D, significant downregulation of ATF3, CAV1, DDR2, GPX3, JAM3 and ZFP36, and prominent upregulation of CDC25A, NOX4, SLC1A5, and SPARC were observed in STAD patients. The gene discussed is SLC1A5; the disease is gastric adenocarcinoma.